Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Isolation and characterization of the TERE1 gene, a gene down-regulated in transitional cell carcinoma of the bladder

Abstract

We have identified a novel cDNA product designated transitional epithelial response gene (TERE1), which was localized to chromosome 1p36. The TERE1 transcript (1.5 and 3.5 kb) is present in most normal human tissues including urothelium, but was reduced or absent in the majority of muscle invasive TCC tumors (22 out of 29 cases). The open reading frame encodes a protein of 338 amino acids (MW 36.8 KD). This protein is 57% homologous to a Drosophila protein called heix. We have shown by Western blotting and immuno-histochemistry with a polyclonal antibody to a specific TERE1 peptide, reduced or absent staining in muscle invasive tumors. Transfection of a sense TERE1 construct resulted in an 80–90% inhibition of cellular proliferation in two TCC cell lines and a lack of aneuploidy in the TERE1-transduced J82 cell line. These data suggest a potential role for this gene product in the progression of bladder cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Abbreviations

TCC:

Transitional Cell Carcinoma of the Bladder

RT–PCR:

reverse transcriptase-polymerase chain reaction

TERE1:

transitional epithelial response gene 1

EST:

expressed sequence tag

References

  • American Joint Committee on Cancer. . 1997 A.J.C.C. Cancer Staging Manual. 5th edn. Lippencott-Raven Publishers: Philadelphia, PA.

  • Ashburner M, Misra S, Roote J, Lewis SE, Blazej R, Davis T, Doyle C, Galle R, George R, Harris N, Hartzell G, Harvey D, Hong L, Houston K, Hoskins R, Johnson G, Martin C, Moshrefi A, Palazzolo M, Reese MG, Spradling A, Tsang G, Wan K, Whitelaw K, Kimmel B, Celniker S and Rubin GM. . 1999 Genetics 153: 179–219.

  • Bieche I, Khodja A and Lidereau R. . 1998 Onco. Rep. 5: 267–272.

  • Boni R, Matt D, Voetmeyer A, Burg G and Zhuang Z. . 1998 J. Invest. Derma. 110: 215–217.

  • Boulikas T. . 1993 Crit. Rev. Euk. Gene Exp. 3: 193–227.

  • Cairns P, Proctor AJ and Knowles MA. . 1991 Oncogene 6: 2305–2309.

  • Cairns P, Evron E, Okami K, Halachmi N, Esteller M, Herman JG, Bose S, Wang SI and Parson R. . 1998 Oncogene 16: 3215–3218.

  • Chang WY, Cairns P, Schoenberg MP, Polascik TJ and Sidransky D. . 1995 Cancer Res. 55: 3246–3249.

  • Chen HL, Chen YC and Chen DS. . 1996 Cancer Gen. Cytogen. 86: 102–106.

  • Chomczynski P and Sacchi N. . 1987 Anal. Biochem. 162: 156–159.

  • Chomczynski P. . 1993 Biotechniques 15: 532–536.

  • deVere White RW and Stapp E. . 1998 Oncology 12: 1717–1723.

  • DiSepio D, Ghosn C, Eckert RI, Deucher A, Robison N, Duvie M, Chandraratna RA and Nagpal S. . 1998 PNAS 95: 14811–14815.

  • Ebrahimi SA, Wang EH, Wu A, Schreck RR, Passaro Jr E and Sawicki MP. . 1999 Cancer Res. 59: 311–315.

  • Fukasawa K, Wiener F, Vande Woude GF and Mai S. . 1997 Oncogene 15: 1295–1302.

  • Giannini AL, Vianco MM and Kypta RM. . 2000 Exp. Cell Res. 255: 207–220.

  • Gasparian AV, Laktionov KK, Belialova MS, Pirogova NA, Tatosvan AG and Zborovskaya IB. . 1998 Br. J. Cancer 77: 1604–1611.

  • Habuchi T, Luscombe M, Elder PA and Knowles MA. . 1998 Genomics 48: 277–288.

  • Hayashi K. . 1991 PCR Meth. Applic. 1: 34–38.

  • Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX and Fornace Jr AJ. . 1999 Nature Genetics 23: 176–184.

  • Hong L and Rubin GM. . 1998 A. Dros. Res. Conf. 39: 373B.

  • Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME and Law M. . 1994 Cancer Res. 54: 531–538.

  • Landis SH, Murray T, Bolden S and Wingo PA. . 2000 Ca Cancer J. Clinic. 49: 8–31.

  • Malkowicz SB. . 1997 Sem. Urol. Onco. 15: 169–178.

  • Martinsson T, Sjoberg RM, Hallstensson K, Nordling M, Hedborg F and Kogner P. . 1997 Eur. J. Cancer 33: 1997–2001.

  • Monteiro AN and Birge RB. . 2000 Ilisto. Histopath. 15: 299–307.

  • Nagai H, Negrini M, Carter SL, Gillum DR, Rosenberg AL, Schwartz GF and Croce CM. . 1995 Cancer Res. 55: 1752–1757.

  • Orlow I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Reuter VE, Zhang ZF, Beach D and Cordon-Cardo C. . 1995 JNCI 87: 1524–1995.

  • Praml C, Finke LH, Herfarth C, Schlag P, Schwab M and Amler L. . 1995 Oncogene 11: 1357–1362.

  • Reznikoff CA, Belair CD, Yeager TR, Savelieva E, Blelloch RH, Puthenveettil JA and Cuthill S. . 1996 Semin. Oncol. 23: 571–584.

  • Rosin MP, Cairns P, Epstein H, Schoenberg MP and Sidransky D. . 1995 Cancer Res. 55: 5213–5216.

  • Salem C, Liang G, Tsai YC, Coulter J, Knowles MA, Feng A-C, Groshen S, Nichols PW and Jones PA. . 2000 Cancer Res. 60: 2473–2476.

  • Sameshima Y, Matsuno Y and Hirohashi S. . 1992 Oncogene 7: 451–457.

  • Sattler HP, Rohde V, Bonkhoff H, Zwergel T and Wullich B. . 1999 Prostate 39: 79–86.

  • Shaw ME and Knowles MA. . 1995 Gene Chr. Cancer 13: 1–8.

  • Simbulan-Rosenthal CM, Haddad BR, Rosenthal DS, Weaver Z, Coleman A, Luo R, Young HM, Wang ZQ, Ried T and Smulson ME. . 1999 PNAS 96: 13191–13196.

  • Simon R, Burger H, Brinkschmidt C, Bocker W, Hertle L and Terpe HJ. . 1998 J. Path. 185: 345–351.

  • Spruck CH, Ohneseit PF, Gonzlacz-Zulueta D, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmutte C, Yang AS and Cote R. . 1994 Cancer Res. 54: 784–788.

  • Steenman M, Redeker B, de Meulemeester M, Wiesmeijer K, Voute PA, Westerveld A, Slater R and Mannens M. . 1997 Cytogenet. Cell Genet. 77: 296–303.

  • Vindeløv LL and Christensen IJ. . 1990 Cytometry 11: 753–770.

  • Wagner U, Bubendorf I, Gasser TC, Moch H, Gorog JP, Richter J, Mihatsch MJ, Waldman FM and Sauter G. . 1997 Am. J. Pathol. 151: 753–759.

  • Williamson MP, Elder PA and Knowles MA. . 1994 Gene Chr. Cancer 9: 108–118.

  • Williamson C, Pannett AA, Pang JT, Wooding C, McCarthy M, Sheppard MN, Monson J, Clayton RN and Thakker RV. . 1997 J. Med. Genet. 34: 617–619.

Download references

Acknowledgements

This study was funded by a Veterans Administration Merit Review grant to SB Malkowicz.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

McGarvey, T., Nguyen, T., Tomaszewski, J. et al. Isolation and characterization of the TERE1 gene, a gene down-regulated in transitional cell carcinoma of the bladder. Oncogene 20, 1042–1051 (2001). https://doi.org/10.1038/sj.onc.1204143

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204143

Keywords

This article is cited by

Search

Quick links